| Item Type | Name |
|
Concept
|
Antigens, Neoplasm
|
|
Concept
|
Amyotrophic Lateral Sclerosis
|
|
Concept
|
Antibiotics, Antineoplastic
|
|
Concept
|
Antibodies, Neoplasm
|
|
Concept
|
Breast Neoplasms
|
|
Concept
|
Adrenergic beta-Antagonists
|
|
Concept
|
Antineoplastic Agents
|
|
Concept
|
Carcinoma, Squamous Cell
|
|
Concept
|
Animals
|
|
Concept
|
Antineoplastic Combined Chemotherapy Protocols
|
|
Concept
|
Analysis of Variance
|
|
Concept
|
Antibodies, Monoclonal
|
|
Concept
|
Antigens, Differentiation, T-Lymphocyte
|
|
Concept
|
Base Sequence
|
|
Concept
|
Cell Count
|
|
Concept
|
Cell Movement
|
|
Concept
|
Astrocytoma
|
|
Concept
|
England
|
|
Concept
|
Carcinoma, Non-Small-Cell Lung
|
|
Concept
|
Cell Division
|
|
Concept
|
United Kingdom
|
|
Concept
|
Cricetulus
|
|
Concept
|
Confidentiality
|
|
Concept
|
Contrast Media
|
|
Concept
|
Facial Nerve
|
|
Concept
|
Graft Survival
|
|
Concept
|
Hospitals, Public
|
|
Concept
|
Enzyme Inhibitors
|
|
Concept
|
Immunologic Factors
|
|
Concept
|
Immunologic Surveillance
|
|
Concept
|
Drosophila melanogaster
|
|
Concept
|
Melanoma, Experimental
|
|
Concept
|
Metalloporphyrins
|
|
Concept
|
Glioma
|
|
Concept
|
Glial Fibrillary Acidic Protein
|
|
Concept
|
Glioblastoma
|
|
Concept
|
Feasibility Studies
|
|
Concept
|
Fibronectins
|
|
Concept
|
Killer Cells, Natural
|
|
Concept
|
Gold
|
|
Concept
|
T-Lymphocytes, Helper-Inducer
|
|
Concept
|
Immune Tolerance
|
|
Concept
|
Enzyme-Linked Immunosorbent Assay
|
|
Concept
|
Hospital Information Systems
|
|
Concept
|
Flow Cytometry
|
|
Concept
|
Fluorescent Antibody Technique
|
|
Concept
|
Immunity, Cellular
|
|
Concept
|
Inflammation
|
|
Concept
|
Macrophages
|
|
Concept
|
Membrane Glycoproteins
|
|
Concept
|
Hospital Bed Capacity, 500 and over
|
|
Concept
|
Pilot Projects
|
|
Concept
|
Mice, Transgenic
|
|
Concept
|
Pain
|
|
Concept
|
Pain, Intractable
|
|
Concept
|
Mesoderm
|
|
Concept
|
Mice, Inbred BALB C
|
|
Concept
|
Mice, Inbred C57BL
|
|
Concept
|
Mice, Nude
|
|
Concept
|
Motor Neurons
|
|
Concept
|
Cricetinae
|
|
Concept
|
Health Policy
|
|
Concept
|
L-Lactate Dehydrogenase
|
|
Concept
|
Ovalbumin
|
|
Concept
|
Lung Neoplasms
|
|
Concept
|
Societies, Scientific
|
|
Concept
|
Immunoenzyme Techniques
|
|
Concept
|
Receptors, Cell Surface
|
|
Concept
|
Interferon-gamma
|
|
Concept
|
Cohort Studies
|
|
Concept
|
Regulatory Sequences, Nucleic Acid
|
|
Concept
|
State Medicine
|
|
Concept
|
Humans
|
|
Concept
|
Leupeptins
|
|
Concept
|
Immunodominant Epitopes
|
|
Concept
|
Sphingomyelins
|
|
Concept
|
Symbiosis
|
|
Concept
|
Tryptophan
|
|
Concept
|
Vaccination
|
|
Concept
|
Histocompatibility Antigens Class I
|
|
Concept
|
Lysosomes
|
|
Concept
|
Th1 Cells
|
|
Concept
|
Randomized Controlled Trials as Topic
|
|
Concept
|
Risk Assessment
|
|
Concept
|
Disease Management
|
|
Concept
|
Insect Proteins
|
|
Concept
|
Reverse Transcriptase Polymerase Chain Reaction
|
|
Concept
|
Central Nervous System Neoplasms
|
|
Concept
|
Antigens, Differentiation, Myelomonocytic
|
|
Concept
|
Antigens, CD
|
|
Concept
|
Lymph Nodes
|
|
Concept
|
CD4-Positive T-Lymphocytes
|
|
Concept
|
Cysteine Proteinase Inhibitors
|
|
Concept
|
Immunotherapy, Adoptive
|
|
Concept
|
Lymphocytes, Tumor-Infiltrating
|
|
Concept
|
Interleukin-10
|
|
Concept
|
Mutagenesis, Site-Directed
|
|
Concept
|
T-Lymphocyte Subsets
|
|
Concept
|
Sigmodontinae
|
|
Concept
|
Medical Oncology
|
|
Concept
|
Melanoma
|
|
Concept
|
Meningeal Neoplasms
|
|
Concept
|
Treatment Outcome
|
|
Concept
|
Neoplasm Metastasis
|
|
Concept
|
Neoplasms, Experimental
|
|
Concept
|
Nerve Regeneration
|
|
Concept
|
Interferon-alpha
|
|
Concept
|
Antigen Presentation
|
|
Concept
|
Sequence Deletion
|
|
Concept
|
Mice, Knockout
|
|
Concept
|
CD8-Positive T-Lymphocytes
|
|
Concept
|
Chemokines
|
|
Concept
|
Disease Progression
|
|
Concept
|
Interleukin-12
|
|
Concept
|
Th2 Cells
|
|
Concept
|
Receptors, CCR5
|
|
Concept
|
Axotomy
|
|
Concept
|
Integrin beta1
|
|
Concept
|
Brain-Derived Neurotrophic Factor
|
|
Concept
|
Receptor Protein-Tyrosine Kinases
|
|
Concept
|
Interleukin-10 Receptor beta Subunit
|
|
Concept
|
Drosophila Proteins
|
|
Concept
|
Receptors, CCR4
|
|
Concept
|
Jurkat Cells
|
|
Concept
|
Intercellular Signaling Peptides and Proteins
|
|
Concept
|
B7-H1 Antigen
|
|
Concept
|
Oligonucleotide Array Sequence Analysis
|
|
Concept
|
Adoptive Transfer
|
|
Concept
|
Lactic Acid
|
|
Concept
|
Facial Nerve Injuries
|
|
Concept
|
STAT3 Transcription Factor
|
|
Concept
|
Animals, Genetically Modified
|
|
Concept
|
Mice
|
|
Concept
|
Heme Oxygenase-1
|
|
Concept
|
Metal Nanoparticles
|
|
Concept
|
Surveys and Questionnaires
|
|
Concept
|
Severity of Illness Index
|
|
Concept
|
RNA, Messenger
|
|
Concept
|
CD11c Antigen
|
|
Concept
|
Rats
|
|
Concept
|
Real-Time Polymerase Chain Reaction
|
|
Concept
|
CTLA-4 Antigen
|
|
Concept
|
Interleukin-2 Receptor alpha Subunit
|
|
Concept
|
Spleen
|
|
Concept
|
Blotting, Western
|
|
Concept
|
NK Cell Lectin-Like Receptor Subfamily K
|
|
Concept
|
Toll-Like Receptor 2
|
|
Concept
|
Toll-Like Receptor 4
|
|
Concept
|
Survival Analysis
|
|
Concept
|
Electronic Health Records
|
|
Concept
|
Tuberous Sclerosis
|
|
Concept
|
Minor Histocompatibility Antigens
|
|
Concept
|
Survival Rate
|
|
Concept
|
Skin Transplantation
|
|
Concept
|
Polymerase Chain Reaction
|
|
Concept
|
G2 Phase
|
|
Concept
|
Chemokine CCL2
|
|
Concept
|
DNA Methylation
|
|
Concept
|
Glucocorticoid-Induced TNFR-Related Protein
|
|
Concept
|
Interleukin-13 Receptor alpha2 Subunit
|
|
Concept
|
Interleukin-17
|
|
Concept
|
Xenograft Model Antitumor Assays
|
|
Concept
|
Gene Knockdown Techniques
|
|
Concept
|
Cell Lineage
|
|
Concept
|
Health Care Surveys
|
|
Concept
|
T-Lymphocytes, Regulatory
|
|
Concept
|
gp100 Melanoma Antigen
|
|
Concept
|
Nanoparticles
|
|
Concept
|
CLOCK Proteins
|
|
Concept
|
Immune Evasion
|
|
Concept
|
RNA, Small Interfering
|
|
Concept
|
Antibodies, Monoclonal, Murine-Derived
|
|
Concept
|
Pain Management
|
|
Concept
|
Lectins, C-Type
|
|
Concept
|
Programmed Cell Death 1 Receptor
|
|
Concept
|
Nanomedicine
|
|
Concept
|
Toll-Like Receptors
|
|
Concept
|
Kaplan-Meier Estimate
|
|
Concept
|
Interleukin-10 Receptor alpha Subunit
|
|
Concept
|
Receptors, CCR8
|
|
Concept
|
Chemokine CCL11
|
|
Concept
|
Neuroimaging
|
|
Concept
|
Brain Neoplasms
|
|
Concept
|
Clinical Trials as Topic
|
|
Concept
|
Disease Models, Animal
|
|
Concept
|
Doxorubicin
|
|
Concept
|
Family Practice
|
|
Concept
|
Follow-Up Studies
|
|
Concept
|
Kynurenic Acid
|
|
Concept
|
Longitudinal Studies
|
|
Concept
|
Lymphocyte Activation
|
|
Concept
|
Magnetic Resonance Imaging
|
|
Concept
|
Microscopy, Fluorescence
|
|
Concept
|
Protoporphyrins
|
|
Concept
|
Receptors, Antigen, T-Cell
|
|
Concept
|
Retrospective Studies
|
|
Concept
|
T-Lymphocytes
|
|
Concept
|
Thymus Gland
|
|
Concept
|
Injury Severity Score
|
|
Concept
|
5'-Nucleotidase
|
|
Concept
|
Immunophenotyping
|
|
Concept
|
DNA Primers
|
|
Concept
|
Sickness Impact Profile
|
|
Concept
|
Disease-Free Survival
|
|
Concept
|
Coculture Techniques
|
|
Concept
|
Microscopy, Electron, Transmission
|
|
Concept
|
Chemokine CXCL11
|
|
Concept
|
GPI-Linked Proteins
|
|
Academic Article
|
Phenotype of CD4+ T cell subsets that develop following mouse facial nerve axotomy.
|
|
Academic Article
|
Bone marrow mesenchymal stem cells loaded with an oncolytic adenovirus suppress the anti-adenoviral immune response in the cotton rat model.
|
|
Academic Article
|
Receptor tyrosine kinase signaling regulates different modes of Groucho-dependent control of Dorsal.
|
|
Academic Article
|
Blood-brain barrier permeable gold nanoparticles: an efficient delivery platform for enhanced malignant glioma therapy and imaging.
|
|
Academic Article
|
Fibrin-binding, peptide amphiphile micelles for targeting glioblastoma.
|
|
Academic Article
|
Durable therapeutic efficacy utilizing combinatorial blockade against IDO, CTLA-4, and PD-L1 in mice with brain tumors.
|
|
Academic Article
|
Molecular Pathways: Targeting IDO1 and Other Tryptophan Dioxygenases for Cancer Immunotherapy.
|
|
Academic Article
|
CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells.
|
|
Academic Article
|
Developmental therapeutics for patients with breast cancer and central nervous system metastasis: current landscape and future perspectives.
|
|
Academic Article
|
The Boosting Potential of Bacteria in Cancer Immunotherapy.
|
|
Academic Article
|
Challenges and future of biomarker tests in the era of precision oncology: Can we rely on immunohistochemistry (IHC) or fluorescence in situ hybridization (FISH) to select the optimal patients for matched therapy?
|
|
Academic Article
|
The interplay among psychological distress, the immune system, and brain tumor patient outcomes.
|
|
Academic Article
|
CD73: an emerging checkpoint for cancer immunotherapy.
|
|
Academic Article
|
Advanced Age Increases Immunosuppression in the Brain and Decreases Immunotherapeutic Efficacy in Subjects with Glioblastoma.
|
|
Academic Article
|
Targeting CD73 to augment cancer immunotherapy.
|
|
Academic Article
|
Tryptophan metabolism in brain tumors - IDO and beyond.
|
|
Academic Article
|
Information management and technology in England's large acute NHS hospitals. National strategy versus local reality.
|
|
Concept
|
Superoxide Dismutase-1
|
|
Concept
|
Antineoplastic Agents, Immunological
|
|
Concept
|
ErbB Receptors
|
|
Academic Article
|
Anti-aquaporin-4 immunoglobulin G/anti-myelin oligodendrocyte glycoprotein immunoglobulin G double-positive paraneoplastic neurological syndrome in a patient with triple-negative breast cancer.
|